Gan & Lee Pharmaceuticals Co., Ltd.SSE: 603087

(603087)"Gan & Lee Pharmaceuticals"Announcement on Obtaining the Ethiopian Drug Registration Approval for Insulin Aspart Injection

· Issued by Gan & Lee Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603087 · · 2 pages · Chinese

Summary by 6ix AI

Gan & Lee Pharmaceuticals Co., Ltd. has announced that it has received drug registration approval for Insulin Aspart Injection in Ethiopia, allowing for its import and sale in the country.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603087gan-and-lee-pharmaceuticalsannouncement-on-obtaining-the-ethiopian-drug-registration-approval-for-insulin-aspart-injection

Release

Announcement on Obtaining the Ethiopian Drug Registration Approval for Insulin Aspart Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Gan & Lee Pharmaceuticals Co., Ltd. on 6ix

Story so far

Earlier from Gan & Lee Pharmaceuticals

Later from Gan & Lee Pharmaceuticals

All Gan & Lee Pharmaceuticals news releases